Kondo H, Sakamoto F, Kawakami K, Tsukamoto G
Pharmaceuticals Research Center, Kanebo, Ltd., Osaka, Japan.
J Med Chem. 1988 Jan;31(1):221-5. doi: 10.1021/jm00396a035.
Several 3-formylquinolone derivatives (8a-c) were synthesized to assay the antibacterial activity both in vitro and in vivo. In vitro, all of the compounds 8a-c showed lower activity than that of the corresponding 3-carboxyl compounds 1a-c, and in vivo, they showed higher activity than that of compounds 1a-c. After oral administration of 3-formyl compounds 8a-c to mice, the compounds were rapidly metabolized into 3-carboxyl compounds 1a-c. In particular, the 3-formyl derivative (8a) of norfloxacin (NFLX, 1a) gave a 2-fold higher serum level than that of NFLX and functioned as a prodrug of NFLX.
合成了几种3-甲酰基喹诺酮衍生物(8a - c),以测定其体外和体内抗菌活性。在体外,所有化合物8a - c的活性均低于相应的3-羧基化合物1a - c;而在体内,它们的活性高于化合物1a - c。给小鼠口服3-甲酰基化合物8a - c后,这些化合物迅速代谢为3-羧基化合物1a - c。特别是,诺氟沙星(NFLX,1a)的3-甲酰基衍生物(8a)的血清水平比诺氟沙星高2倍,并起到了诺氟沙星前药的作用。